We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. ×
Market Research Report

Global Precision Medicine Market Analysis by Aspects, by Traget Disease, by Technology & by Target User with COVID-19 impact on the market | Forecast (2020-2030)

Published Date :

2020-09-01

Report Pages :

870

Format :

PdF/PPT/XLS/Hard Copy

Region Covered :

Global

Market Landscape & Analysis 

The concept of ‘Precision Medicine’ is currently somewhere between dream and road to reality, however, slowly but surely real revenues are appearing, and realistic models for future growth will be seen. With the advent of personalized therapies - drugs, vaccines and others in the market, comes the risk and therapies associated with the global precision medicine market. The global precision medicine market was valued at USD 46.2 billion in 2017 and is expected to witness a robust CAGR of 10.7% during the forecast period (2020-2030).  

Initiatives Towards The implementation of Precision Medicine 

  • Kalydeco (ivacaftor) and Keytruda (pembrolizumab) are the two drugs recently approved by FDA, pertaining to 33 cystic fibrosis mutations and cancer treatment based on a genetic feature respectively, point to an encouraging future for precision medicine.  
  • In 2015, Pfizer, Inc. installed Center of Excellence in Precision Medicine (CEPM) in Chile, in alliance with Thermo Fisher Scientific, to ratify new, more accurate, and less invasive technologies for detection of cancer.  
  • In 2017, NCI has also instigated various precision medicine trials, which comprises of Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST), Lung Cancer Master Protocol (Lung-MAP), Molecular Analysis of Therapy Choice (NCI-MATCH), and Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT).  
  • NanoString launched nCounter Low RNA Input Kit, generates high-quality gene expression profiling of up to 800 gene targets from as little as 1 nanogram of sample.  
  • The All of Us Research Program awarded funds USD 28.6 million to establish three genome centers across the country to generate genomic data from biosamples contributed by the program’s participants. Eventually, this information will become a critical component in the program’s precision medicine research platform, a national resource to support studies on a variety of important health questions. 

Precision Medicine: An Approach to Manage Novel Coronavirus Pneumonia  

With the genome sequencing the genetic sequence of 2019-nCoV was found homologous to that of severe acute respiratory syndrome-associated coronavirus. Several patients with pneumonia of an unknown cause were detected in Wuhan, China. On 7 January 2020. As of 29 January 2020, the virus had been diagnosed in more than 7000 patients in China and 77 patients in other countries. Given that the virus has a strong ability to spread between individuals, it is of top priority to identify potential or suspected patients as soon as possible—or the virus may cause a serious pandemic. Therefore, a precision medicine approach to managing this disease is urgently needed for detecting and controlling the spread of the virus. 

Precision Medicine tends to facilitate decision-making by health care workers with necessary clinical information, laboratory detection, and imaging findings. The approach consists of the following four parts: screening, diagnosis, preventive control, and treatment of 2019-CoV pneumonia. To preventing and treating various viral pneumonia, including those caused by coronaviruses, it is believed that such an approach would help in preventing further the spreading of 2019-nCoV. 


Precision Medicine Market Taxonomy 

By Aspects 

  • Screening for Disease Risk  

  • Early diagnosis  

  • Therapy Selection and Monitoring 

By Target Disease Areas 

  • Oncology 

  • CNS 

  • Immunology 

  • Respiratory 

  • Others 

By Technology 

  • Big Data Analytics 

  • Bioinformatics 

  • Gene sequencing 

  • Drug Discovery 

  • Companion Diagnostic 

  • Others 

By Target User 

  • Diagnostic tool companies 

  • Healthcare IT/ Big data companies 

  • Pharma & Biotech companies 

  • Clinical Labs 

 

COVID-19 impact on "Global Precision Medicine Market"

The report analyses and includes complete detailed chapter of 50-70 pages about the short term & long terms impact of COVID-19 outbreak on each segment of "Global Precision Medicine Market" along with government measures to support the sector. It also showcases the current market landscape during COVID, impact of the virus on leading companies, expected demand schedule and supply chain in the industry and other various major factors. This will help you identify those companies that may benefit from this pandemic as well as those that will lose out.

Precision Medicine Companies profiled in this report

Major In-Vitro Diagnostics Players 

  • Abbott Diagnostics 
  • Beckman Coulter Inc.  
  • Becton, Dickinson and Company 
  • Bio-Rad Laboratories, Inc. 
  • bioMérieux Inc. 
  • Celera Corporation 
  • Cepheid 
  • Dako Denmark A/S 
  • Danaher Corporation 
  • Fujirebio Diagnostics, Inc. 
  • GE Healthcare 
  • Gen-Probe Inc. 
  • Illumina 
  • Immucor, Inc. 
  • LabCorp 
  • Luminex Corporation 
  • Ortho Clinical Diagnostics 
  • PerkinElmer Inc. 
  • Phadia AB 
  • QIAGEN N.V. 
  • Quest Diagnostics 
  • Roche Diagnostics 
  • Siemens Healthcare Diagnostics 
  • Sysmex Corporation 
  • Thermo Fisher Scientific Inc. 
  • Ventana Medical Systems Inc. 
  • Wako Diagnostics 

Supporters 

  • uBiome 
  • OxSynBio 
  • SUN Bioscience 
  • Pathwork Diagnostics, Inc. 
  • Power3 Medical Products, Inc. 
  • Precision Therapeutics 
  • Predictive Biosciences 
  • Autogenomics Inc. 
  • BG Medicine, Inc. 
  • Biocare Medical, LLC 
  • Biocartis SA 
  • Rules-Based Medicine, Inc. 
  • Saladax Biomedical, Inc. 
  • Sequenom, Inc. 
  • TGen (The Translational Genomics Research Institute) 
  • TrimGen Corporation 
  • Quest Diagnostics Incorporated 
  • Response Genetics, Inc. 
  • Rosetta Genomics 
  • TrovaGene, Inc. 
  • Virco BVBA 
  • XDx, Inc. 
  • Veridex, LLC 
  • Vermillion Inc. 
  • Biocept, Inc. 
  • BioCurex, Inc. 
  • Biodesix, Inc. 
  • BioReference Laboratories, Inc. 
  • BioServe 
  • bioTheranostics 
  • Clarient Inc. 
  • CombiMatrix Molecular Diagnostics, Inc. 
  • Corgenix Medical Corporation 
  • Cylex, Inc. 
  • Dana Farber Cancer Instit 
  • Progenika Inc. 
  • Prometheus Laboratories Inc. 
  • Quest Diagnostics Incorporated 
  • Response Genetics, Inc. 
  • Rosetta Genomics 
  • Rules-Based Medicine, Inc. 

New Entrants 

  • IRIS International, Inc. 
  • ViennaLab Diagnostics GmbH 
  • Pharmigene 
  • Pinpoint Genomics, Inc. 
  • Population Diagnostics, Inc. 
  • Proctor & Gamble 
  • Psynomics Incorporated 
  • Radient Pharmaceuticals Corporation 
  • ScreenCell 
  • Scripps Health 
  • Seegene Inc. 
  • Signal Genetics 
  • Signature Diagnostics AG 
  • Sirius Genomics 
  • Skyline Diagnostics B.V. 
  • Spartan Bioscience Inc. 
  • SureGene, LLC 
  • TcLand Expression SA 
  • Transgenomic, Inc. 
  • Caris Life Sciences 
  • Chronix Biomedical 
  • Crescendo Bioscience, Inc. 
  • Critical Diagnostics 
  • Curidium Medica Limited 
  • CvergenX 
  • DermaGenoma, Inc. 
  • DiaTech Oncology 
  • Eutropics Pharmaceuticals 
  • Everist Genomics 
  • Evotec AG 
  • Exosome Diagnostics Inc. 
  • Foundation Medicine Inc. 
  • GeneNews Limited 
  • Abkine Pharmaceuticals 
  • Accelerated Medical Diagnostics, LLC 
  • Advanced Biological Laboratories 
  • Affomix Corporation 
  • Ahram Biosystems, Inc. 
  • Alacris Theranostics GmbH 
  • Amoy Diagnostics Co. Ltd. 
  • ApoCell, Inc. 
  • Atossa Genetics, Inc. 
  • Augurex Life Sciences Corp. 
  • Biofortuna Ltd. 
  • Biomarker Factory, The 
  • BioMarker Strategies 
  • Biomedical Diagnostics 
  • BlackBio S.L. 
  • Genetic Technologies Limited 
  • GenMark Diagnostics Inc. 
  • Bostwick Laboratories 
  • Cancer Genetics, Inc. 
  • Cancer Treatment Centers of America 
  • CancerGuide Diagnostics, Inc. 
  • CardioDx, Inc. 
  • Caris Life Sciences 
  • Chronix Biomedical 
  • Crescendo Bioscience, Inc. 
  • Critical Diagnostics 
  • Curidium Medica Limited 
  • CvergenX 
  • DermaGenoma, Inc. 
  • DiaTech Oncology 
  • Eutropics Pharmaceuticals 
  • Everist Genomics 
  • Evotec AG 
  • Exosome Diagnostics Inc. 
  • Foundation Medicine Inc. 
  • GeneNews Limited 
  • Genetic Technologies Limited 
  • GenMark Diagnostics Inc. 
  • Genomas 
  • Genomind, LLC 
  • GenoVive LLC 
  • GMS Biotech 
  • Med BioGene, Inc. 
  • Medco Health Solutions Inc. 
  • Metamark Genetics, Inc. 
  • Mira Dx 
  • Molecular Response 
  • MolecularMD Corp. 
  • Nanostring Technologies, Inc. 
  • NaturalNano, Inc. 
  • NewGene 
  • NobleGen Biosciences 
  • Nodality Inc. 
  • Novartis Molecular Diagnostics 
  • Nuvera Biosciences, Inc. 
  • On-Q-ity 
  • Orion Genomics 
  • OvaGene Oncology, Inc. 
  • Proctor & Gamble 
  • Psynomics Incorporated 
  • Radient Pharmaceuticals Corporation 
  • ScreenCell 
  • Scripps Health 
  • Seegene Inc. 
  • Signal Genetics 
  • Signature Diagnostics AG 
  • Sirius Genomics 
  • Skyline Diagnostics B.V. 
  • Spartan Bioscience Inc. 
  • SureGene, LLC 

Healthcare IT Players 

  • EXOCHAIN 
  • Desktop Genetics 
  • OxSynBio 
  • Sophia Genetics 
  • Deep Genomics 
  • Resurgo Genetics 
  • Kenzen 
  • Horizon Discovery 
  • Healthcoin 
  • Prognos 
  • Mimetas 
  • ReviveMed 
  • Tute Genomics 
  • Curoverse 
  • Syapse 
  • Teckel Medical 
  • Babyscripts 
  • Oncora Medical 
  • Presage Bioscience 
  • Arthro Therapeutics 
  • Adaptive Biotechnologies 
  • CLC bio 
  • CollabRx 
  • Definiens 
  • Dell Healthcare and Life Sciences 
  • DNA Direct 
  • GenomeQuest Inc. 
  • HolGenTech Inc. 
  • IDBS 
  • MediSapiens Ltd. 
  • Partners HealthCare Center for Personalized Genetic Medicine 
  • Selventa 
  • Sophic Systems Alliance 

Covered in this global precision medicine market report

  • Role of Precision Medicine to decode the solution for COVID-19 outbreak & the impact of this pandemic on Precision Medicine Market. 
  • How remodeling the “One-Size-Fits-All” theory to individually-tailored therapy is impacting the precision medicine market? 
  • What are the current and future precision medicine market outlook in the developed and emerging markets? 
  • What are the in-depth quantitative and qualitative analyses of the roof safety and access system of the market? 
  • Our market study also comprises of detailed explanation on reimbursement of novel tests, payor perspectives and policies, regulatory issues and personalized medicine assays, IVD vs CLIA or both, patent issues and commercializing personalized, diagnostics, prospects for POC testing. 
  • What are the key market strategies to implement and penetrate the concept of precision medicine in North America, Europe, Asia Pacific, Latin America and Middle East & Africa region? What are the notable areas of strategic focus across influential countries? 
  • This report also defines the best practices in the field of precision medicine, role of stakeholders, current value assessment frameworks and potential societal value in precision medicine market. 
  • What are the potent market entry strategies for diagnostics, pharma & biotech, and healthcare IT companies to finance on precision medicine? What are the propitious go-to-market strategy to succeed in the field of precision medicine? 
  • What are the Value Assessment Frameworks and Product/ Service Promotion Strategies for precision medicine market? 
  • Detailed competitive landscape: Acquisitions & Mergers, New Therapy Launch, Agreements, Partnerships, Collaborations and Joint Ventures, Research and Development, Therapy and Regional Expansion.  
  • Initiatives have been introduced a new module of patient-centric research to provide new tools, technologies, and therapies to clinicians-Small Business Technology Transfer (STTR), Cancer Diagnosis Program, Cancer Imaging Program, Cancer Therapy Evaluation Program, Cancer Moonshot 2020, and S4S Program. 

For a full detailed overview, send here request for market report sample.

 



{ }

Global Precision Medicine Market Analysis by Aspects, by Traget Disease, by Technology & by Target User with COVID-19 impact on the market | Forecast (2020-2030)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Table of Contents

BROWSE SIMILAR REPORTS

Please Select Linenece Type